{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:21:26Z","timestamp":1780392086739,"version":"3.54.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zewail City of Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03350-5","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:27:08Z","timestamp":1772065628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fortified Long-acting Ocular Gel Laden with Nanoformulated Dexamethasone for Dry Eye Therapy"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4461-3076","authenticated-orcid":false,"given":"Aya A.","family":"Refaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-7898","authenticated-orcid":false,"given":"Sarah","family":"Yahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8179-437X","authenticated-orcid":false,"given":"Ibrahim M.","family":"El-Sherbiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"3350_CR1","doi-asserted-by":"publisher","unstructured":"Lazreg S, Hosny M, Ahad MA, Sinjab MM, Messaoud R, Awwad ST, Rousseau A. Dry eye disease in the Middle East and Northern Africa: a position paper on the current state and unmet needs. Clin Ophthalmol. 2024;18:679\u2013698. https:\/\/doi.org\/10.2147\/OPTH.S436027.","DOI":"10.2147\/OPTH.S436027"},{"key":"3350_CR2","doi-asserted-by":"crossref","unstructured":"Kumari S, Dandamudi M, Rani S, Behaeghel E, Behl G, Kent D, et al. Dexamethasone-loaded nanostructured lipid carriers for the treatment of dry eye disease. Pharmaceutics [Internet]. 2021 Jun 1;13(6):905. Available from: https:\/\/www.mdpi.com\/1999-4923\/13\/6\/905\/htm. Accessed 12 June\u00a02025.","DOI":"10.3390\/pharmaceutics13060905"},{"key":"3350_CR3","doi-asserted-by":"publisher","unstructured":"Yu F, Zheng M, Zhang AY, Han Z. A cerium oxide-loaded glycol chitosan nano-system for the treatment of dry eye disease. J Control Release [Internet]. 2019;315:40. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.039.","DOI":"10.1016\/j.jconrel.2019.10.039"},{"issue":"14 Special Issu","key":"3350_CR4","doi-asserted-by":"publisher","first-page":"DES7","DOI":"10.1167\/iovs.17-23475","volume":"59","author":"J Shimazaki","year":"2018","unstructured":"Shimazaki J. Definition and diagnostic criteria of dry eye disease: Historical overview and future directions. Invest Ophthalmol Vis Sci. 2018;59(14 Special Issue):DES7-12.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3350_CR5","doi-asserted-by":"crossref","unstructured":"Baranowski P, Karolewicz B, Gajda M, Pluta J. Ophthalmic drug dosage forms: characterization and research methods.\u00a0Sci World J [Internet]. 2014;2014:861904. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3977496\/. Accessed 19 Aug 2025.","DOI":"10.1155\/2014\/861904"},{"key":"3350_CR6","doi-asserted-by":"crossref","unstructured":"Nagai N, Otake H. Novel drug delivery systems for the management of dry eye. Adv Drug Deliv Rev [Internet]. 2022;191. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36283491\/. Accessed 19 Aug 2025.","DOI":"10.1016\/j.addr.2022.114582"},{"key":"3350_CR7","doi-asserted-by":"crossref","unstructured":"Mohamed HB, Abd El-Hamid BN, Fathallah D, Fouad EA. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sci [Internet]. 2022;175:106206. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0928098722000914?via%3Dihub. Accessed 31 July 2025.","DOI":"10.1016\/j.ejps.2022.106206"},{"key":"3350_CR8","doi-asserted-by":"crossref","unstructured":"Gote V, Sikder S, Sicotte J, Pal D. Ocular drug delivery: present innovations and future challenges. J Pharmocol Exp Ther [Internet]. 2019;370(3):602\u201324. Available from: https:\/\/jpet.aspetjournals.org\/action\/showFullText?pii=S0022356524260341. Accessed 31 July 2025.","DOI":"10.1124\/jpet.119.256933"},{"key":"3350_CR9","doi-asserted-by":"crossref","unstructured":"Gagliano C, Papa V, Amato R, Malaguarnera G, Avitabile T. Measurement of the retention time of different ophthalmic formulations with ultrahigh-resolution optical coherence tomography. Curr Eye Res [Internet]. 2018;43(4):499\u2013502. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/02713683.2017.1418893. Accessed 15 July 2025.","DOI":"10.1080\/02713683.2017.1418893"},{"key":"3350_CR10","doi-asserted-by":"crossref","unstructured":"Eldesouky LM, El-Moslemany RM, Ramadan AA, Morsi MH, Khalafallah NM. Cyclosporine lipid nano capsules as thermo-responsive gel for dry eye management: promising corneal mucoadhesion, biodistribution, and preclinical efficacy in rabbits. Pharmaceutics [Internet]. 2021;13(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33803242\/. Accessed 19 Aug 2025.","DOI":"10.3390\/pharmaceutics13030360"},{"key":"3350_CR11","doi-asserted-by":"crossref","unstructured":"Cohen S, Martin A, Sall K. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose. Clin Ophthalmol [Internet]. 2013;8:157. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3883617\/. Accessed 17 July 2025.","DOI":"10.2147\/OPTH.S53822"},{"key":"3350_CR12","unstructured":"SYSTANE Gel Drops | Systane Canada [Internet]. Available from: https:\/\/systane.myalcon.com\/en-ca\/products\/systane-gel-drops\/. Accessed 10 June 2025."},{"key":"3350_CR13","doi-asserted-by":"crossref","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.\u00a0Drug Deliv Transl Res [Internet]. 2020;11(3):866\u201393. Available from: https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00843-z. Accessed 23 Nov 2025.","DOI":"10.1007\/s13346-020-00843-z"},{"issue":"3","key":"3350_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, Benitez-del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II Management and Therapy Report. Ocular Surface. 2017;15(3):575\u2013628.","journal-title":"Ocular Surface"},{"issue":"3","key":"3350_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocular Surf. 2017;15(3):438\u2013510.","journal-title":"Ocular Surf"},{"key":"3350_CR16","doi-asserted-by":"crossref","unstructured":"Nelson JD, Craig JP, Akpek EK, Azar DT, Belmonte C, Bron AJ, et al. TFOS DEWS II Introduction. Ocular Surf [Internet]. 2017;15(3):269\u201375. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28736334\/. Accessed 27 Jan 2025.","DOI":"10.1016\/j.jtos.2017.05.005"},{"key":"3350_CR17","doi-asserted-by":"crossref","unstructured":"Papangkorn K, Prendergast E, Higuchi JW, Brar B, Higuchi WI. Noninvasive ocular drug delivery system of dexamethasone sodium phosphate in the treatment of experimental uveitis rabbit. liebertpub.comK Papangkorn, E Prendergast, JW Higuchi, B Brar, WI Higuchi.\u00a0J Ocul Pharmacol Ther [Internet]. 2017;33(10):753\u201362. Available from: https:\/\/www.liebertpub.com\/doi\/abs\/10.1089\/jop.2017.0053. Accessed 10 June 2025.","DOI":"10.1089\/jop.2017.0053"},{"key":"3350_CR18","doi-asserted-by":"crossref","unstructured":"Szalai B, Budai-Sz\u0171cs M, Kov\u00e1cs A, Berk\u00f3 S, Gr\u00f3f I, Deli MA, et al. The effect of mucoadhesive polymers on ocular permeation of thermo-responsive in situ gel containing dexamethasone\u2013cyclodextrin complex. Int J Pharm [Internet]. 2024;667(Pt A). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39447934\/. Accessed 23 Nov 2025.","DOI":"10.1016\/j.ijpharm.2024.124848"},{"key":"3350_CR19","unstructured":"Internal document code 1 maxd221222cNZ MAXIDEX TM Eye Drops 0.1%. Available from: www.medsafe.govt.nz. Accessed 12 June 2025."},{"key":"3350_CR20","doi-asserted-by":"crossref","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.\u00a0Drug Deliv Transl Res [Internet]. 2020;11(3):866\u201393. Available from: https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00843-z. Accessed 30 Nov 2025.","DOI":"10.1007\/s13346-020-00843-z"},{"key":"3350_CR21","doi-asserted-by":"publisher","unstructured":"Nagai N, Ishii M, Seiriki R, Ogata F, Otake H, Nakazawa Y, Okamoto N, Kanai K, Kawasaki N. Novel sustained-release drug delivery system for dry eye therapy by rebamipide nanoparticles. Pharmaceutics. 2020;12(2):155. https:\/\/doi.org\/10.3390\/pharmaceutics12020155.","DOI":"10.3390\/pharmaceutics12020155"},{"key":"3350_CR22","doi-asserted-by":"crossref","unstructured":"Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, et al. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv [Internet]. 2020;10(46):27835\u201355. Available from: https:\/\/pubs.rsc.org\/en\/content\/articlehtml\/2020\/ra\/d0ra04971a. Accessed 12 June 20253","DOI":"10.1039\/D0RA04971A"},{"key":"3350_CR23","doi-asserted-by":"crossref","unstructured":"Ana R da, Fonseca J, Karczewski J, Silva AM, Zieli\u0144ska A, Souto EB. Lipid-based nanoparticulate systems for the ocular delivery of bioactive with anti-inflammatory properties. Int J Mol Sci [Internet]. 2022;23(20):12102. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9603520\/. Accessed 12 Dec 2025.","DOI":"10.3390\/ijms232012102"},{"key":"3350_CR24","doi-asserted-by":"crossref","unstructured":"Modi DM, Modi AD. Polysaccharide-based nanogels and ocular drug delivery: The emerging nanocarrier for crossing blood retinal barrier.\u00a0Carbohydr Polym Technol Appl [Internet]. 2023;6:100331. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S266689392300052X?utm_source=chatgpt.com. Accessed 12 Dec 2025.","DOI":"10.1016\/j.carpta.2023.100331"},{"key":"3350_CR25","doi-asserted-by":"crossref","unstructured":"Paliwal R, Paliwal S, Sulakhiya K, Kurmi BK, Kenwat R, Mamgain A. 4 - Chitosan-based nanocarriers for ophthalmic applications. Elsevier [Internet];\u00a02019. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780081025536000040. Accessed 11 Dec 2025.","DOI":"10.1016\/B978-0-08-102553-6.00004-0"},{"key":"3350_CR26","doi-asserted-by":"crossref","unstructured":"Sander C, Nielsen HM, Jacobsen J. Buccal delivery of metformin: TR146 cell culture model evaluating the use of bio adhesive chitosan discs for drug permeability enhancement. Int J Pharm [Internet]. 2013;458(2):254\u201361. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24148665\/. Accessed\u00a0 3 May 2025.","DOI":"10.1016\/j.ijpharm.2013.10.026"},{"key":"3350_CR27","doi-asserted-by":"crossref","unstructured":"Calvo P, Remu\u00f1an-L\u00f3pez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan\/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res [Internet]. 1997;14(10):1431\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9358557\/. Accessed 3 May 2025.","DOI":"10.1023\/A:1012128907225"},{"key":"3350_CR28","doi-asserted-by":"crossref","unstructured":"Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: Preparation and in vitro study. Int J Nanomedicine [Internet]. 2012;7:1851\u201363. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22605934\/. Accessed 3 May 2025.","DOI":"10.2147\/IJN.S26365"},{"key":"3350_CR29","doi-asserted-by":"crossref","unstructured":"Arafa K, Shamma RN, El-Gazayerly ON, El-Sherbiny IM. Facile development, characterization, and optimization of new metformin-loaded nanocarrier system for efficient colon cancer adjunct therapy. Drug Dev Ind Pharm [Internet]. 2018;44(7):1158\u201370. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/03639045.2018.1438463. Accessed 3 May 2025.","DOI":"10.1080\/03639045.2018.1438463"},{"key":"3350_CR30","doi-asserted-by":"crossref","unstructured":"Hynnekleiv L, Magno M, Vernhardsdottir RR, Moschowits E, T\u00f8nseth KA, Dartt DA, et al. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol [Internet]. 2022;100(8):844. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9790727\/. Accessed 19 Aug 2025.","DOI":"10.1111\/aos.15159"},{"key":"3350_CR31","doi-asserted-by":"crossref","unstructured":"Kotla NG, Bonam SR, Rasala S, Wankar J, Bohara RA, Bayry J, et al. Recent advances and prospects of hyaluronan as a multifunctional therapeutic system.\u00a0J Control Release [Internet]. 2021;336:598\u2013620. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34237401\/. Accessed 17 May 2025.","DOI":"10.1016\/j.jconrel.2021.07.002"},{"key":"3350_CR32","doi-asserted-by":"crossref","unstructured":"Vogel R, Crockett RS, Oden N, Laliberte TW, Molina L. Demonstration of Efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (Vismed, Rejena). Am J Ophthalmol [Internet]. 2010;149(4):594\u2013601. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20346777\/. Accessed 12 June 2025.","DOI":"10.1016\/j.ajo.2009.09.023"},{"key":"3350_CR33","doi-asserted-by":"crossref","unstructured":"Seino S, Matsuoka R, Masuda Y, Kunou M, Okada Y, Saika S. Topical hyaluronan alone promotes corneal epithelial cell migration, whereas combination with benzalkonium chloride impairs epithelial wound healing. Cutan Ocular Toxicol [Internet]. 2020;39(1):13\u201320. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15569527.2019.1673402. Accessed 17 June 2025.","DOI":"10.1080\/15569527.2019.1673402"},{"key":"3350_CR34","doi-asserted-by":"crossref","unstructured":"Posarelli C, Passini A, Del Re M, Fogli S, Toro MD, Ferreras A, et al. Cross-linked hyaluronic acid as tear film substitute.\u00a0J Ocul Pharmacol Ther\u00a0[Internet]. 2019;35(7):381\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31373862\/. Accessed 17 July 2025.","DOI":"10.1089\/jop.2018.0151"},{"key":"3350_CR35","doi-asserted-by":"crossref","unstructured":"Salwowska NM, Bebenek KA, \u017b\u0105d\u0142o DA, Wcis\u0142o-Dziadecka DL. Physiochemical properties and application of hyaluronic acid: a systematic review. J Cosmet Dermatol [Internet]. 2016 Dec 1 [cited 2025 May 15];15(4):520\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27324942\/.","DOI":"10.1111\/jocd.12237"},{"key":"3350_CR36","doi-asserted-by":"publisher","unstructured":"Baishya H. Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets. J Dev Drugs. https:\/\/doi.org\/10.4172\/2329-6631.1000171.","DOI":"10.4172\/2329-6631.1000171"},{"key":"3350_CR37","doi-asserted-by":"publisher","unstructured":"Gilbert S. Banker JSCR. Modern pharmaceutics. 4th ed. Vol. 2. In: Gilbert S. Banker JSCR, editors. Modern pharmaceutics. CRC Press;2002. pp. 94\u2013140. https:\/\/doi.org\/10.1201\/9780824744694.","DOI":"10.1201\/9780824744694"},{"key":"3350_CR38","doi-asserted-by":"crossref","unstructured":"Bruno SG, Mart\u00ednez SM, Costa Gobbato C, Quinteros DA, Alaimo A, P\u00e9rez OE. Chitosan-TPP nanogels for ocular delivery of folic acid: release profile, corneal permeation, and mucoadhesion assessment. Pharmaceutics [Internet]. 2025;17(4):424. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12030068\/. Accessed 27 Nov 2025.","DOI":"10.3390\/pharmaceutics17040424"},{"key":"3350_CR39","doi-asserted-by":"crossref","unstructured":"Albarkah YA, Green RJ, Khutoryanskiy VV. Probing the mucoadhesive interactions between porcine gastric mucin and some water-soluble polymers. Macromol Biosci [Internet]. 2015;15(11):1546\u201353. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26102520\/. Accessed 4 Dec 2025","DOI":"10.1002\/mabi.201500158"},{"key":"3350_CR40","doi-asserted-by":"crossref","unstructured":"Mendes AC, Moreno JS, Hanif M, Douglas TEL, Chen M, Chronakis IS. Morphological, mechanical and mucoadhesive properties of electrospun chitosan\/phospholipid hybrid nanofibers.\u00a0Int J Mol Sci\u00a0[Internet]. 2018;19(8):2266. Available from: https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2266\/htm. Accessed 30 Nov 2025.","DOI":"10.3390\/ijms19082266"},{"key":"3350_CR41","doi-asserted-by":"crossref","unstructured":"Kapadia W, Qin N, Zhao P, Phan CM, Haines L, Jones L, et al. Shear-thinning and temperature-dependent viscosity relationships of contemporary ocular lubricants. Transl Vis Sci Technol [Internet]. 2022;11(3):1. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8899858\/. Accessed 9 Dec 2025.","DOI":"10.1167\/tvst.11.3.1"},{"key":"3350_CR42","doi-asserted-by":"crossref","unstructured":"Sideek SA, El-Nassan HB, Fares AR, Elkasabgy NA, ElMeshad AN. Cross-linked alginate dialdehyde\/chitosan hydrogel encompassing curcumin-loaded bilosomes for enhanced wound healing activity. Pharmaceutics [Internet]. 2024;16(1):90. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10819348\/. Accessed 9 Dec 2025.","DOI":"10.3390\/pharmaceutics16010090"},{"issue":"7","key":"3350_CR43","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1167\/iovs.18-23860","volume":"59","author":"X Li","year":"2018","unstructured":"Li X, Kang B, Woo IH, Eom Y, Lee HK, Kim HM, et al. Effects of topical mucolytic agents on the tears and ocular surface: a plausible animal model of mucin-deficient dry eye. Invest Ophthalmol Vis Sci. 2018;59(7):3104\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3350_CR44","unstructured":"Khutoryanskiy V. Advances in mucoadhesive polymers and formulations for transmucosal drug delivery. Advances in Mucoadhesive Polymers and Formulations for Transmucosal Drug Delivery [Internet]. 2020;206. Available from: https:\/\/www.mdpi.com\/books\/reprint\/2235. Accessed 30 Nov 2025."},{"key":"3350_CR45","doi-asserted-by":"crossref","unstructured":"Motamedifar A, Ghafouri H, Alizadeh N. Hyaluronic acid-coated magnetic solid lipid nanoparticles for cancer-targeted delivery of gemcitabine and imaging agent.\u00a0Carbohydr Polym Technol Appl\u00a0[Internet]. 2025;11:100946. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2666893925002877?utm_source=chatgpt.com. Accessed 4 Dec 2025.","DOI":"10.1016\/j.carpta.2025.100946"},{"key":"3350_CR46","doi-asserted-by":"crossref","unstructured":"Yasser M, El Naggar EE, Elfar N, Teaima MH, El-Nabarawi MA, Elhabal SF. Formulation, optimization and evaluation of ocular gel containing nebivolol HCl-loaded ultra-deformable Spanlastics nanovesicles: in vitro and in vivo studies. Int J Pharm X [Internet]. 2024;7:100228. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2590156723000725?utm_source=chatgpt.com#s0180. Accessed 9 Dec 2025.","DOI":"10.1016\/j.ijpx.2023.100228"},{"key":"3350_CR47","unstructured":"Ramadan MA, Sharaky M, Faid AH. \u201cIonic gelation synthesis, characterization and cytotoxic evaluation of chitosan nanoparticles on different types of human cancer cell models.\u201d Egypt J Chem [Internet]. 2022;65(2):153\u20139. Available from: http:\/\/ejchem.journals.ekb.eg\/. Accessed 16 Oct 2025."},{"key":"3350_CR48","doi-asserted-by":"crossref","unstructured":"Honary S, research FZT Journal of Pharmaceutical, 2013 undefined. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 1). ajol.infoS Honary, F Zahir\u00a0Trop J Pharm Res\u00a0[Internet]. 2013;12(2):255\u201364. Available from: https:\/\/www.ajol.info\/index.php\/tjpr\/article\/view\/88554. Accessed 13 Aug 2025.","DOI":"10.4314\/tjpr.v12i2.19"},{"key":"3350_CR49","doi-asserted-by":"crossref","unstructured":"Baspinar Y, Borchert HH. Penetration and release studies of positively and negatively charged nano emulsions\u2014Is there a benefit of the positive charge? Int J Pharm [Internet]. 2012;430(1\u20132):247\u201352. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378517312002815. Accessed 19 Aug 2025.","DOI":"10.1016\/j.ijpharm.2012.03.040"},{"key":"3350_CR50","doi-asserted-by":"crossref","unstructured":"Zimmer A, Kreuter J. Microspheres, and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev [Internet]. 1995;16(1):61\u201373. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/0169409X95000172?via%3Dihub. Accessed 28 July 2025.","DOI":"10.1016\/0169-409X(95)00017-2"},{"key":"3350_CR51","doi-asserted-by":"crossref","unstructured":"Zhang C, Yin Y, Zhao J, Li Y, Wang Y, Zhang Z, et al. An update on novel ocular nano systems with possible benefits in the treatment of corneal neovascularization. Int J Nanomedicine [Internet]. 2022;17:4911\u201331. Available from: https:\/\/www.dovepress.com\/an-update-on-novel-ocular-nanosystems-with-possible-benefits-in-the-tr-peer-reviewed-fulltext-article-IJN. Accessed 16 Oct 2025.","DOI":"10.2147\/IJN.S375570"},{"key":"3350_CR52","doi-asserted-by":"crossref","unstructured":"Zhao LY, Zhang WM. Recent progress in drug delivery of Pluronic P123: pharmaceutical perspectives. J Drug Target [Internet]. 2017;25(6):471\u201384. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28135859\/. Accessed 16 Oct 2025.","DOI":"10.1080\/1061186X.2017.1289538"},{"key":"3350_CR53","doi-asserted-by":"crossref","unstructured":"Akrami-Hasan-Kohal M, Chouchou A, Blanquer S, Sharkawi T. Everolimus-encapsulation in Pluronic P123 self-assembled micelles as drug delivery systems for drug-coated balloons. Int J Pharm X [Internet]. 2024;7:100230. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11636783\/. Accessed 16 Oct 2025.","DOI":"10.1016\/j.ijpx.2024.100230"},{"key":"3350_CR54","doi-asserted-by":"crossref","unstructured":"Jiang T, Wang Y, Yu Z, Du L. Synthesis, characterization of chitosan\/tripolyphosphate nanoparticles loaded with 4-chloro-2-methylphenoxyacetate sodium salt and its herbicidal activity against Bidens Pilosa L. Sci Rep [Internet]. 2024;14(1):1\u201312. Available from: https:\/\/www.nature.com\/articles\/s41598-024-69438-9. Accessed 16 Oct 2025.","DOI":"10.1038\/s41598-024-69438-9"},{"key":"3350_CR55","doi-asserted-by":"crossref","unstructured":"Espinosa-Cano E, Aguilar MR, Portilla Y, Barber DF, Rom\u00e1n JS. Anti-inflammatory polymeric nanoparticles based on ketoprofen and dexamethasone. Pharmaceutics [Internet]. 2020;12(8):1\u201318. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32751993\/. Accessed 16 Oct 2025.","DOI":"10.3390\/pharmaceutics12080723"},{"key":"3350_CR56","doi-asserted-by":"crossref","unstructured":"Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali NM, et al. Chitosan and its derivatives for ocular delivery formulations: recent advances and developments. Polymers (Basel) [Internet]. 2020;12(7):1519. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7407599\/. Accessed 16 Oct 2025.","DOI":"10.3390\/polym12071519"},{"key":"3350_CR57","doi-asserted-by":"crossref","unstructured":"Bernkop-Schn\u00fcrch A,\u00a0D\u00fcnnhaupt S. Chitosan-based drug delivery systems.\u00a0Eur J Pharm Biopharm\u00a0[Internet]. 2012;81(3):463\u20139. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0939641112001038. Accessed 2 Sept 2025.","DOI":"10.1016\/j.ejpb.2012.04.007"},{"issue":"2","key":"3350_CR58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.carbpol.2010.04.074","volume":"82","author":"R Jayakumar","year":"2010","unstructured":"Jayakumar R, Menon D, Manzoor K, Nair SV, Tamura H. Biomedical applications of chitin and chitosan-based nanomaterials\u2014A short review. Carbohydras Polym. 2010;82(2):227\u201332.","journal-title":"Carbohydras Polym"},{"key":"3350_CR59","doi-asserted-by":"crossref","unstructured":"Cui N, Dai CY, Mao X, Lv X, Gu Y, Lee ES, et al. Poloxamer-based scaffolds for tissue engineering applications: a review. Gels [Internet]. 2022;8(6):360. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9222596\/. Accessed 19 Aug 2025.","DOI":"10.3390\/gels8060360"},{"key":"3350_CR60","doi-asserted-by":"crossref","unstructured":"Ganguly R, Kumar S, Tripathi A, Basu M, Verma G, Sarma HD, et al. Structural and therapeutic properties of Pluronic\u00ae P123\/F127 micellar systems and their modulation by salt and essential oil. J Mol Liq [Internet]. 2020;310:113231. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167732220309375. Accessed 19 Aug 2025.","DOI":"10.1016\/j.molliq.2020.113231"},{"key":"3350_CR61","doi-asserted-by":"crossref","unstructured":"Senthilkumar M, Dash S, Vigneshwari R, Paulraj E. Aceclofenac-loaded Pluronic F108\/L81 mixed polymeric micelles: effect of HLB on solubilization. Des Monomers Polym [Internet]. 2022;25(1):1. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8803101\/. Accessed 10 June 2025.","DOI":"10.1080\/15685551.2022.2028373"},{"key":"3350_CR62","doi-asserted-by":"crossref","unstructured":"Alkholief M, Kalam MA, Raish M, Ansari MA, Alsaleh NB, Almomen A, et al. Topical sustained-release dexamethasone-loaded chitosan nanoparticles: assessment of drug delivery efficiency in a rabbit model of endotoxin-induced uveitis. Pharmaceutics [Internet]. 2023;15(9):2273. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10537057\/. Accessed 28 July 2025.","DOI":"10.3390\/pharmaceutics15092273"},{"key":"3350_CR63","doi-asserted-by":"publisher","unstructured":"Silva MM, Calado R, Marto J, Bettencourt A, Almeida AJ, Gon\u00e7alves LMD. Chitosan nanoparticles as a mucoadhesive drug delivery system for ocular administration. Mar Drugs. 2017;15(12):370. https:\/\/doi.org\/10.3390\/md15120370.","DOI":"10.3390\/md15120370"},{"key":"3350_CR64","doi-asserted-by":"crossref","unstructured":"Racaniello GF, Balenzano G, Arduino I, Iacobazzi RM, Lopalco A, Lopedota AA, et al. Chitosan and anionic solubility enhancer sulfa butyl ether-\u03b2-cyclodextrin-based nanoparticles as dexamethasone ophthalmic delivery system for anti-inflammatory therapy. Pharmaceutics [Internet]. 2024;16(2):277. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10893235\/. Accessed 27 July 2025.","DOI":"10.3390\/pharmaceutics16020277"},{"key":"3350_CR65","doi-asserted-by":"crossref","unstructured":"Bugnicourt L, Alcouffe P, Ladavi\u00e8re C. Elaboration of chitosan nanoparticles: favorable impact of a mild thermal treatment to obtain finely divided, spherical, and colloidally stable objects. Colloids Surf a Physicochemist Eng Asp [Internet]. 2014;457(1):476\u201386. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0927775714005676?via%3Dihub. Accessed 27 July 2025.","DOI":"10.1016\/j.colsurfa.2014.06.029"},{"key":"3350_CR66","doi-asserted-by":"crossref","unstructured":"Szalai B, J\u00f3j\u00e1rt-Laczkovich O, Kov\u00e1cs A, Berk\u00f3 S, Balogh GT, Katona G, et al. Design and optimization of in situ gelling mucoadhesive eye drops containing dexamethasone. Gels [Internet]. 2022;8(9):561. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9498616\/. Accessed 27 July 2025.","DOI":"10.3390\/gels8090561"},{"key":"3350_CR67","doi-asserted-by":"crossref","unstructured":"Ashique S, Mishra N, Mohanto S, Gowda BHJ, Kumar S, Raikar AS, et al. Overview of processed excipients in ocular drug delivery: opportunities so far and bottlenecks. Heliyon [Internet]. 2024;10(1):e23810. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405844023110188. Accessed 16 Oct 2025.","DOI":"10.1016\/j.heliyon.2023.e23810"},{"key":"3350_CR68","doi-asserted-by":"crossref","unstructured":"Georgiev GA, Eftimov P, Yokoi N. Contribution of mucins towards the physical properties of the tear film: a modern update. Int J Mol Sci [Internet]. 2019;20(24):6132. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6941008\/. Accessed 19 Aug 2025.","DOI":"10.3390\/ijms20246132"},{"key":"3350_CR69","doi-asserted-by":"crossref","unstructured":"Srinivasan S, Garofalo R, Williams R. Safe and effective management of dry eye symptoms with hydroxypropyl guar and hyaluronic acid dual-polymer lubricating eye drops: a review of preclinical and clinical studies. Clin Ophthalmol [Internet]. 2023;17:3883. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10725649\/. Accessed 17 July 2025.","DOI":"10.2147\/OPTH.S428725"},{"issue":"273","key":"3350_CR70","doi-asserted-by":"publisher","first-page":"132700","DOI":"10.1016\/j.ijbiomac.2024.132700","volume":"1","author":"TJ Wang","year":"2024","unstructured":"Wang TJ, Rethi L, Ku MY, Nguyen HT, Chuang AEY. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments. Int J Biol Macromol. 2024;1(273):132700.","journal-title":"Int J Biol Macromol"},{"key":"3350_CR71","doi-asserted-by":"crossref","unstructured":"De Campos AM, Diebold Y, Carvalho ELS, S\u00e1nchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity.\u00a0Pharm Res\u00a0[Internet]. 2004;21(5):803\u201310. Available from: https:\/\/link.springer.com\/article\/10.1023\/B:PHAM.0000026432.75781.cb. Accessed 12 June 2025.","DOI":"10.1023\/B:PHAM.0000026432.75781.cb"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03350-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:52:14Z","timestamp":1780390334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03350-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":71,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3350"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03350-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"116"}}